Revenue Summary of BIOTON S.A.

BIOTON S.A.'s latest annual revenue in 2023 was 181.63 Million PLN , down -22.1% from previous year.
BIOTON S.A.'s latest quarterly revenue in 2024 Q2 was 50.61 Million PLN , up 35.03% from previous quarter.
BIOTON S.A. reported a annual revenue of 233.15 Million PLN in annual revenue 2022, up 43.01% from previous year.
BIOTON S.A. reported a annual revenue of 163.03 Million PLN in annual revenue 2021, down -26.49% from previous year.
BIOTON S.A. reported a quarterly revenue of 37.48 Million PLN for 2024 Q1, down -21.13% from previous quarter.
BIOTON S.A. reported a quarterly revenue of 50.7 Million PLN for 2023 Q3, up 3.39% from previous quarter.

Annual Revenue Chart of BIOTON S.A. (2023 - 2005)

Historical Annual Revenue of BIOTON S.A. (2023 - 2005)

Year	Revenue	Revenue Growth
2023	181.63 Million PLN	-22.1%
2022	233.15 Million PLN	43.01%
2021	163.03 Million PLN	-26.49%
2020	221.78 Million PLN	9.78%
2019	202.03 Million PLN	-16.23%
2018	241.16 Million PLN	-33.31%
2017	361.64 Million PLN	30.27%
2016	277.61 Million PLN	-31.35%
2015	404.4 Million PLN	7.18%
2014	377.3 Million PLN	10.85%
2013	340.35 Million PLN	-16.23%
2012	406.3 Million PLN	40.6%
2011	288.98 Million PLN	-23.67%
2010	378.59 Million PLN	32.27%
2009	286.22 Million PLN	-2.48%
2008	293.51 Million PLN	8.33%
2007	270.94 Million PLN	25.74%
2006	215.47 Million PLN	42.15%
2005	151.58 Million PLN	0.0%

Year	Revenue	Revenue Growth
2024 Q2	50.61 Million PLN	35.03%
2024 Q1	37.48 Million PLN	-21.13%
2023 Q3	50.7 Million PLN	3.39%
2023 Q2	49.04 Million PLN	42.68%
2023 Q1	34.37 Million PLN	-55.69%
2023 FY	181.63 Million PLN	-22.1%
2023 Q4	47.52 Million PLN	-6.27%
2022 Q2	48.05 Million PLN	-3.98%
2022 Q3	57.49 Million PLN	19.65%
2022 Q4	77.57 Million PLN	34.94%
2022 FY	233.15 Million PLN	43.01%
2022 Q1	50.04 Million PLN	19.58%
2021 FY	163.03 Million PLN	-26.49%
2021 Q1	36.82 Million PLN	-59.56%
2021 Q4	41.84 Million PLN	-12.51%
2021 Q2	36.53 Million PLN	-0.78%
2021 Q3	47.83 Million PLN	30.92%
2020 Q4	91.04 Million PLN	109.56%
2020 FY	221.78 Million PLN	9.78%
2020 Q1	37.1 Million PLN	-31.33%
2020 Q2	50.18 Million PLN	35.25%
2020 Q3	43.44 Million PLN	-13.43%
2019 Q1	30.74 Million PLN	-21.99%
2019 Q2	72.31 Million PLN	135.23%
2019 Q3	44.93 Million PLN	-37.87%
2019 Q4	54.03 Million PLN	20.25%
2019 FY	202.03 Million PLN	-16.23%
2018 Q3	48.39 Million PLN	-42.61%
2018 Q1	69.03 Million PLN	-39.6%
2018 FY	241.16 Million PLN	-33.31%
2018 Q2	84.32 Million PLN	22.16%
2018 Q4	39.41 Million PLN	-18.57%
2017 Q4	114.29 Million PLN	24.31%
2017 FY	361.64 Million PLN	30.27%
2017 Q3	91.94 Million PLN	7.17%
2017 Q2	85.79 Million PLN	23.23%
2017 Q1	69.62 Million PLN	1004.39%
2016 Q4	6.3 Million PLN	-92.93%
2016 FY	277.61 Million PLN	-31.35%
2016 Q1	84.44 Million PLN	-16.69%
2016 Q2	97.72 Million PLN	15.73%
2016 Q3	89.13 Million PLN	-8.79%
2015 FY	404.4 Million PLN	7.18%
2015 Q4	101.36 Million PLN	-10.05%
2015 Q3	112.69 Million PLN	15.32%
2015 Q2	97.71 Million PLN	5.49%
2015 Q1	92.63 Million PLN	-18.72%
2014 FY	377.3 Million PLN	10.85%
2014 Q3	106.82 Million PLN	33.65%
2014 Q2	79.93 Million PLN	4.39%
2014 Q4	113.97 Million PLN	6.69%
2014 Q1	76.57 Million PLN	-17.3%
2013 FY	340.35 Million PLN	-16.23%
2013 Q4	92.59 Million PLN	13.75%
2013 Q2	79.7 Million PLN	-8.01%
2013 Q1	86.65 Million PLN	-2.38%
2013 Q3	81.4 Million PLN	2.13%
2012 Q2	69.02 Million PLN	-57.26%
2012 Q1	161.48 Million PLN	129.89%
2012 FY	406.3 Million PLN	40.6%
2012 Q3	87.02 Million PLN	26.08%
2012 Q4	88.76 Million PLN	2.0%
2011 Q3	82.62 Million PLN	1.89%
2011 FY	288.98 Million PLN	-23.67%
2011 Q1	55.01 Million PLN	-71.18%
2011 Q2	81.09 Million PLN	47.4%
2011 Q4	70.24 Million PLN	-14.98%
2010 Q1	54.2 Million PLN	-53.55%
2010 Q3	62.67 Million PLN	-11.46%
2010 FY	378.59 Million PLN	32.27%
2010 Q4	190.92 Million PLN	204.63%
2010 Q2	70.78 Million PLN	30.6%
2009 Q3	51.68 Million PLN	-16.48%
2009 Q4	116.69 Million PLN	125.8%
2009 Q2	61.88 Million PLN	10.56%
2009 Q1	55.97 Million PLN	0.0%
2009 FY	286.22 Million PLN	-2.48%
2008 FY	293.51 Million PLN	8.33%
2007 FY	270.94 Million PLN	25.74%
2006 FY	215.47 Million PLN	42.15%
2005 FY	151.58 Million PLN	0.0%

Peer Revenue Comparison of BIOTON S.A.

Name	Revenue	Revenue Difference
Bioceltix S.A.	- PLN	-Infinity%
Captor Therapeutics Spolka Akcyjna	13.2 Million PLN	-1275.926%
Mabion S.A.	151.67 Million PLN	-19.751%
Molecure S.A.	100.00 PLN	-181635900.0%
NanoGroup S.A.	2019.00 PLN	-8996234.819%
Pharmena S.A.	9.83 Million PLN	-1746.457%
Poltreg S.A.	1.39 Million PLN	-12883.274%
Pure Biologics Spólka Akcyjna	95 Thousand PLN	-191095.789%
Ryvu Therapeutics S.A.	46.86 Million PLN	-287.614%
Synthaverse S.A.	58.6 Million PLN	-209.922%
Urteste S.A.	- PLN	-Infinity%

Global Stocks Search

BIOTON S.A. (BIO.WA)

Revenue Summary of BIOTON S.A.

Annual Revenue Chart of BIOTON S.A. (2023 - 2005)

Historical Annual Revenue of BIOTON S.A. (2023 - 2005)

Peer Revenue Comparison of BIOTON S.A.